algonquinpediatrics.com

      
      

       McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is recalling five product lots
       as an addition to the list of products included in the company's January 15th, 2010
       product recall. The additional lots involved are four product lots of BENADRYL ®
       ALLERGY ULTRATAB™ TABLETS, 100 count, sold in the U.S.; and one product lot of
       EXTRA STRENGTH TYLENOL® Rapid Release Gels, 50 count, sold in the U.S., Trinidad
       and Tobago, Bermuda, and Puerto Rico (FULL RECALLED PRODUCT LIST BELOW).

       This recall is a follow-up to the product recall that McNeil Consumer Healthcare
       announced on January 15th, 2010 and is being taken because the products were
       inadvertently omitted from the initial recall action. McNeil Consumer Healthcare identified
       the omission and informed the U.S. Food and Drug Administration (FDA) of its decision
       to add these product lots to the recall list. All of these products were produced before the
       January 15^th, 2010 recall. Since January, McNeil Consumer Healthcare has continued to
       analyze and evaluate 2,4,6-tribromoanisole (TBA) and has shared that information with
       the FDA. This further analysis confirms that the risk of serious adverse medical events is
       remote. This recall is being conducted with the knowledge of the FDA.

       To read the full story, click here.

       NOTE: APL did not sell any of the above products.

       Respectfully,

       The Physicians of APL
                                                                                                          ^ Top of Page